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The first TSE1 Roadmap2, provided an outline of possible future changes to EU 
measures on TSEs in the short, medium and long-term while still making food safety 
and consumer protection the highest priority. The majority of short and medium term 
actions envisaged in the first TSE Roadmap have been achieved and the positive 
trend already observed in 2005 in the Bovine Spongiform Encephalopathy (BSE) 
epidemic has continued since then. At the same time, the impact of BSE on human 
health appears to be more limited than initially feared.
This Communication is complemented by a Commission Staff Working Document 
(CSWD) where Annexes referred to in the Communication can be found and which 
inter alia includes an overview of the achievements of the first TSE roadmap over 
the period 2005-2009.
The goal for the coming years is to continue the review of the measures while 
assuring a high level of food safety. Amendments to the TSE rules are and will 
continue to be taken following a stepwise approach supported by a solid scientific 
basis. In this respect, the scientific advice provided by the European Food Safety 
Authority (EFSA) should continue to play a crucial role to consider future policy 
options. It is also of paramount importance to continue research in those areas where 
information is lacking or gaps exist which do not allow firm decisions to be taken.
The aim of this Communication is to outline future possible amendments allowing a 
review of the measures to align them with the situation where the EU is finally on the 
last pathway to eradicate BSE within its cattle population. However vigilance should 
be ensured in order to continue to monitor the situation in case of a potential re-
emergence of BSE or emergence of a new TSE agent in cattle population. 
This review should be primarily driven by scientific advice and technical issues 
related to the control and enforcement of the new measures.
  
1 TSE = Transmissible Spongiform Encephalopathy (see definition in Annex I to CSWD).
2 COM(2005) 322 FINAL of 15 July 2005.
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2. ACTIONS ENVISAGED FOR THE PERIOD 2010 – 2015
2.1. Further revision of the list/age limit for Specified Risk Materials (SRM)
Strategic goal: 
To ensure and maintain the current level of consumer protection by continuing to 
assure safe removal of SRM but modify list/age based on new & evolving scientific 
opinions.
2.1.1. Current legislation
Specified Risk Materials (SRM) are the organs considered to harbour the BSE 
infectivity in an animal affected by BSE. In the EU, the removal of SRM from the food 
and feed chains is mandatory since 2000. The removal of SRM is the most important 
public health protection measure. The list of SRM is established based on scientific 
knowledge and a high level of precaution. The restrictions on the use of SRM include a 
prohibition to use certain products for the production of derived products for use in food 
and feed such as tallow, gelatine, collagen and dicalcium phosphate.
2.1.2. Future policy options
Any amendment of the current list of SRM should be based on new evolving scientific 
knowledge while maintaining the existing high level of consumer protection within the 
EU. However, the list of SRM to be removed from the food and feed chains should also 
take into account the epidemiological situation based on the data gained from BSE 
surveillance. EFSA is currently conducting a reassessment of the pertinence of the SRM 
list in small ruminants and the final opinion should be available by the end of 2010. 
Since it is impossible, however, to consider the complete elimination of risk as a 
realistic objective for any risk management decision, the scientific advice should aim 
for a quantitative or a semi-quantitative approach taking into account the favourable 
epidemiological situation regarding BSE in the European Union. The alignment of the 
EU SRM list with the international standards of World Organisation for Animal Health 
(OIE) should be sought (in particular for bovine intestines) if supported by solid 
scientific advice based on quantitative risk assessments. The current obligation for 
Member States benefiting from a negligible risk status according to the OIE Code3 to 
remove SRM from the food and feed chain could be reviewed if an increasing number 
of Member States reaches the negligible status for which no SRM list has been 
established.
2.2. Further revision of the feed ban
Strategic goal: 





2.2.1. Current legislation 
A ban on the feeding of mammalian meat and bone meal (MBM) to cattle, sheep and 
goats was introduced as of July 1994. In order to manage the risk of presence of 
prohibited material in ruminant feed through cross-contamination, this partial ban was 
extended to a total EU wide suspension on the use of processed animal proteins (PAP) 
in feed for any animals farmed for the production of food on 1 January 2001 with some 
exceptions like the use of fish meal for non ruminants. Any presence of prohibited 
constituents of animal origin in feed breaches the feed ban since the legislation does not 
provide for any tolerance.
The table below illustrates the current provisions of the feed ban:







Pets and fur 
animals
Processed animal proteins except blood 
meal and fish meal NA NA NA A
Blood meal from ruminants NA NA NA A
Blood products from ruminants NA NA NA A
Gelatine from ruminants NA NA NA A
Hydrolysed proteins other than those 
derived from non ruminants or from 
ruminant hides and skins
NA NA NA A
Blood meal from non ruminants NA NA A A
Fishmeal NA4 A A A
Blood products from non ruminants NA A A A
Di and tricalcium phosphate of animal 
origin NA A A A
Hydrolysed proteins from non 
ruminants or from ruminant hides and 
skins
A A A A
Non ruminant gelatine A A A A
Egg, egg products, milk, milk products, 
colostrum A A A A
Animal proteins other than the above-
mentioned ones NA A A A
  
4 Milk replacers containing fishmeal and intended only for unweaned ruminants are authorised.
EN 7 EN
A = authorised
NA = not authorised
2.2.2. Ongoing Research
As part of its annual work programme, the Community Reference Laboratory for animal 
proteins (CRL-AP) in feed investigated the strength of the microscopic method 
regarding the quantitative determination of animal constituents in feedingstuffs (to 
estimate the total amount of animal proteins in feed which is needed to allow the 
introduction of any tolerance level in feedingstuffs). The preliminary results of this 
evaluation revealed that the current method is not reliable for the purpose of 
quantification.
In addition, the CRL-AP is investigating the performance of different new diagnostic 
methods which may identify the species (ruminant, pig or poultry) of traces of MBM 
found in feed. Indeed, the mandatory treatment of mammalian proteins at 133°C, 3 Bars 
during 20 minutes results in very small fragments of animal proteins which are difficult
to detect by the current analytical methods. The results of this study should be available 
during the second half of 2010.
2.2.3. Possible gradual lifting of the feed ban
The starting point when revising the current feed ban provisions should be risk-based 
but at the same time should take into account the control tools in place to evaluate (i.e. 
the availability of a reliable test to identify the species of trace of MBM).
– Tolerance level for PAP in feed for farmed animals
In order to apply a risk-based approach in case prohibited PAP has been detected, a 
certain tolerance level may be established.
On December 2009, the Commission asked EFSA to provide an updated quantitative 
risk assessment on the risk linked to small amounts of processed animal proteins in 
feed. The EFSA opinion is expected by the end of 2010. Based on the EFSA 
conclusions, an introduction of a tolerance level with regard to a very small presence of 
PAP in feed may be proposed without jeopardising the current eradication measures.
– Lifting feed ban provisions for non-ruminants (pigs, poultry, fishes)
Currently, PAP forbidden for feeding purposes are used mainly to produce fertilizers, 
compost or carburant for cement works. However, PAP may be a source of proteins for 
non-ruminant farmed animals which need to be fed with high quality proteins. 
Considering that the transmission risk of BSE from non ruminants to non-ruminants is 
very unlikely, a lifting of the ban on the use of PAP from non-ruminants in non-
ruminant feed could be considered, but without lifting the existing prohibition on intra-
species recycling (e.g. poultry MBM could only be fed to pigs and pig MBM to 
poultry). Moreover the reintroduction of PAP in non-ruminant feed may enable the EU 
to decrease the dependence on other sources of proteins.
Such a measure would however be acceptable only if validated analytical techniques to 
determine the species origin of PAP are available. In addition, considering the limitation 
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inherent in any control method, correct channelling of PAP from different species will 
be an important part of any review of the current feed ban provisions. The valorisation 
of PAP for feeding purposes will have to be compared to the investments needed to 
comply with the channelling requirements.
2.3. Further revision of BSE surveillance
Strategic goal: 
To continue to adapt the BSE monitoring system in bovine animals with a better 
targeting of the surveillance activity while keeping the capacity to monitor the 
evolution of the epidemiological situation and to assess the effectiveness of the 
protective measures in place.
2.3.1. Current legislation 
The goal of the surveillance is to monitor and assess the effectiveness of control 
measures taken such as the feed ban and SRM removal by following the evolution of 
BSE prevalence over the years.
According to TSE legislation, each Member State shall carry out an annual monitoring 
programme for BSE including a screening procedure using rapid tests approved for that 
purpose. This programme shall cover as a minimum all bovine animals above 30 
months of age slaughtered normally for human consumption (healthy slaughtered 
animals) and all bovine animals above 24 months of age which have died/been killed or 
been sent for emergency slaughter (risk animals).
However, a Member State which can demonstrate, based on epidemiological criteria, 
the improvement of the BSE situation on its territory may send an application to the 
Commission with a view to being authorised to revise its monitoring programme. Since 
2009, 17 Member States5 have been authorised to review their monitoring programmes 
and to raise the age limit for testing to 48 months based on their favourable 
epidemiological situation and following positive EFSA opinions.
This increase in age limit for testing has led to a diminution of roughly 30 % of the 
number of tests performed annually in the EU in 2009 compared to 2008 (Chart 1 in 
Annex III to CSWD) while keeping the same capacity to provide a reliable insight into 
the prevalence and evolution of BSE in the Member States. The same diminution can be 
observed for the costs associated to the detection of one BSE case in slaughterhouse 
(they have dropped from € 14,15 Million in 2008 to € 10,1 Million in 2009, see Chart 3 
in Annex III to CSWD).
2.3.2. Future policy options
Depending on the results of the ongoing monitoring programmes, a further revision of 
the BSE monitoring programmes may be envisaged for Member States complying with 
epidemiological criteria. Such options could include: 
  
5 Belgium, Cyprus, Denmark, Germany, Ireland, Greece, Spain, France, Italy, Luxembourg, Netherlands, 
Portugal, Austria, Slovenia, Finland, Sweden, United Kingdom.
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– the continuation of the gradual increase in the age limits for testing of all healthy 
slaughtered animals and risk animals;
– testing of a statistical sample size of bovine animals above a certain age in each 
subpopulation (healthy slaughtered and risk animals);
– testing of bovine animals in each subpopulation based on their date of birth and 
the effective implementation of the feed ban.
Any future option should allow the continuous detection of an increase in BSE epidemic 
or an emergence of new TSE strains. In particular, since atypical BSE cases were 
detected over the last few years in animals older than 8 years old in the EU, any revision 
of BSE surveillance should not impair the detection of these cases. In addition, due to 
the single market and the free movement of bovine animals between Member States, the 
practical aspects in terms of control should not be disregarded and any new system put 
in place should remain easily manageable. Finally, in the mid-term, the revision of BSE 
surveillance should not prevent Member States from maintaining their OIE status as 
regards BSE risk.
2.4. Further revision of scrapie eradication measures 
Strategic goal: 
To adapt the current eradication measures in TSE infected flocks of sheep and 
goats to bring them in line with the latest scientific knowledge and to develop 
sustainable tools to control TSE in small ruminant flocks in the EU.
2.4.1. Current legislation
The current provisions for the eradication of TSEs in sheep flocks are based on a 
combination of different tools (total or selective culling of susceptible animals in 
infected flocks, breeding programmes to select for resistance to TSEs in high genetic 
merit flocks, restocking with resistant animals and reinforced surveillance in infected 
flocks). For goat herds, total culling is the only option applicable if classical scrapie is 
detected.
Special measures are however in place for atypical scrapie cases in order to take into 
account their limited spread of infection within a flock: animals are exempted from 
culling but they shall be submitted to an intensified TSE surveillance during two 
breeding years without any possibility to be moved from their herd.
2.4.2. Past and on-going research
In goats, unlike sheep, there is no clearly identified genetic resistance or susceptibility 
to TSEs. In 2008, the final results of an EU funded pilot project study conducted in 
Cyprus and aimed at the identification of the effect of certain genes on scrapie 
resistance/susceptibility in goats seemed to indicate that some genes could be associated 
with resistance/susceptibility to classical scrapie in goats in CY. In view of the 
importance for the EU eradication policy in the goat population, EU funds have been 
allocated for the design and implementation of a protocol for additional studies in order 
to supplement the initial findings of the Cypriot pilot study. This protocol, finalised in 
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September 2009, aims to collect data to gain further knowledge about genetic resistance 
to scrapie in goats. First results should be available in 2011.
Furthermore, a scientific assessment jointly performed by EFSA and the European 
Centre for Disease Prevention and Control (ECDC) on any possible association between 
TSEs in animals and humans is ongoing and the results of this work could be of great 
interest as regards the zoonotic potential of TSEs in small ruminants.
2.4.3. Future policy options
The high complexity of TSEs in small ruminants (due mainly to the existence of 
different strains of prions), the current uncertainties as regards their zoonotic potential 
and the great diversity of factors influencing the transmission and maintenance of 
scrapie within and between flocks make it necessary to continue the reflection on the 
future legislative actions to take in order to control TSE in small ruminant flocks in the 
EU. The following actions could be considered:
– to establish the conditions for small ruminants herd certification as regards TSE 
based on results of rapid tests and on OIE guidelines in order to avoid the 
inadvertent spread of scrapie through infected preclinical animals;
– to further adapt measures for atypical scrapie if scientific data confirms that this 
scrapie strain is not contagious;
– to take advantage of genetic resistance in goats if further research indicates 
genetic resistance of certain genotypes within the goat population;
– to continue to encourage genetic control of scrapie in sheep through breeding 
programmes (while avoiding inbreeding or genetic drift) as these programmes 
appear to be effective at controlling the disease.
In any case, future research results and scientific advice concerning TSE in small 
ruminants will be the key elements influencing future policy options.
2.5. Cohort culling in bovine animals
Strategic goal:
To review the culling policy in BSE infected herds.
2.5.1. Current legislation
In the case of confirmation of a BSE case in a holding, the current rules foresee the 
killing and complete destruction of bovine animals belonging to the "cohort" of the BSE 
case (i.e. bovine animals born in the same herd as the case within 12 months preceding 
or following the date of birth of the case and which may have consumed the same 
contaminated feed as the case). By way of derogation, it is possible to allow a Member 
State to defer the killing and complete destruction of cohort animals until the end of 
their productive lives. Only Germany applied for this derogation so far and was 
authorised to use it in 2007. Furthermore, where the BSE case is a female, its progeny 
born within two years prior to, or after, clinical onset of the disease shall be destroyed.
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2.5.2. Future policy options
As the number of positive animals detected within the cohort animals in the EU is now 
very low (2 in 2008, 0 in 2009), a proposed alternative could be to stop the systematic 
cohort culling and to authorise the slaughtering of these animals for human consumption 
provided that animals are tested with negative results before entering the food chain. 
2.6. Ante-mortem and post-mortem rapid tests
Strategic goal:
To continue to promote the development of the best rapid tests available for 
detecting TSEs.
2.6.1. Current legislation
Only the rapid tests which are listed in the TSE legislation can be used for the 
monitoring of TSE in the EU. Before being able to be listed, any rapid test has to be 
thoroughly evaluated as regards its analytical performances and has to be positively 
recommended to the Commission by EFSA.
2.6.2. On-going activities for the development of laboratory tests
The Commission completed the first evaluation of rapid diagnostic tests for BSE in 
cattle in 1999. Further evaluations of rapid diagnostic tests for TSEs in ruminants have 
subsequently been carried out. In 2007, the Commission, aware that developmental 
work on other tests had continued, decided to launch a new open call for expression of 
interest intended to cover ante and post-mortem tests for the detection of TSE in large 
(cattle) and small (sheep and goats) ruminants. This call was launched for a 5 year 
period and its objectives are to identify new tests and to select those that are suitable for 
inclusion in an evaluation programme based on EFSA scientific protocols. The call 
allows test manufacturers which have tests already at an advanced stage to apply in 
order to have their test evaluated for their suitability to use in the EU TSE surveillance 
programmes.
2.6.3. Future policy option
The option to test live animals if validated ante-mortem tests become available could be 
envisaged. The usefulness of this option for controlling BSE in bovine animals is 
limited nowadays. This option would however be of great help for herd certification in 
small ruminants' herds.
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3. ALTERNATIVE SCENARIOS IF THE POSITIVE TREND DOES NOT CONTINUE IN ALL 
MEMBER STATES AT THE SAME PACE.
The level of protection of consumers should be the same across the EU. But the 
epidemiological situation between the different Member States justifies the situation 
that, where certain Member States would be eligible for further amendments, others 
would not. The practical implementation and practices will therefore force the adoption 
of certain amendments limited to certain Member States. The amendment of the BSE 
surveillance system was an example where only 17 Member States were allowed to 
amend the BSE monitoring programme.
Even if all indicators regarding the prevalence of BSE in bovine animals suggest that a
future increase of BSE cases is unlikely, alternative scenarios should be envisaged if the 
decline in BSE cases is not confirmed in all Member States. 
In that case, more stringent measures regarding SRM removal could be envisaged for 
those Member States with a lower decline of BSE cases. As a final measure, a 
temporary embargo might be envisaged which would allow the situation in the 
individual Member State to be addressed without penalising the other Member States 
where the negative trend is not confirmed.
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4. CONCLUSION
The review of the measures related to TSE must be based on an appropriate assessment 
of the possible risks for human and animal health and must, taking into account existing 
scientific evidence and innovation, maintain or, if scientifically justified, increase the 
level of protection of human and animal health. It is impossible, however, to consider 
the complete elimination of risk as a realistic objective for any risk management 
decision in matters regarding food safety, where the cost and benefits of risk-reducing 
measures have to be carefully weighed in order to ensure the measure’s proportionality. 
It is the role and responsibility of the risk manager to decide the acceptable level of risk, 
taking into account all the elements present in a scientific risk assessment.
Since any amendment will have to be supported by solid scientific advice, it is of 
paramount importance to continue research in those areas where information is lacking 
or gaps exist which do not allow firm decisions to be taken.
In addition, experience over the past two decades has demonstrated that BSE has been 
used abusively for protectionist ends, in particular by third countries. A strong and 
credible international framework is therefore of paramount importance to ensure that 
trade can take place under safe and fair conditions. The EU must take the lead in 
international standard setting bodies to promote European standards and policies, and 
align its legislation with international standards as far as possible.
In setting our future strategy it is also important not to lose sight of other threats to 
animal and public health which have emerged in recent years, such as Salmonella and 
antimicrobial resistance. The balance of evidence is increasingly pointing towards the 
need to better prioritise actions towards diseases which may have a bigger impact than 
TSEs in terms of public health and to set out EU funding accordingly. The encouraging 
trends in relation to BSE merit a considered review of the opportunities to focus on 
these other threats.
